Interview by Dr Neil Love and companion faculty lecture recorded on April 30, 2026. Published July 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.75 credits
MOC types
ABS — Accredited CMEUp to 0.75 pointsABIM — Medical KnowledgeUp to 0.75 pointsABS — Self-AssessmentUp to 0.75 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Address:
- 2 South Biscayne Blvd
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
-
ReleasedJul 18, 2026
-
Last day to claim creditJul 20, 2027 9 months left
-
Research to Practice Oncology Today with Dr Neil Love: First-Line and Maintenance Therapy for Patients with HER2-Positive Metastatic Breast Cancer | 2026 (Interview)
-
Research to Practice Oncology Today with Dr Neil Love: Optimizing the Selection of First-Line and Maintenance Therapy for Patients with Extensive-Stage SCLC | 2026 (Lecture)
-
Research to Practice Oncology Today with Dr Neil Love: Optimizing the Use of Androgen Deprivation Therapy for Patients with Prostate Cancer | 2026 (Lecture)
-
Answers in CME Inc. (AiCME) Refining Care for HR+, HER2+ mBC in the Community: Contextualizing the Data for Emerging First-Line Maintenance Therapies
-
PRIME Education, Inc. (PRIME®) Balancing Efficacy, Safety, and Patient Quality of Life in Management of Metastatic HER2+ Breast Cancer
-
Clinical Care Options, LLC (dba Decera Clinical Education) Optimizing First-line Maintenance for HER2+ MBC: Equipping the Multidisciplinary Team With the Latest Evidence and Guidance on Novel Regimens
